Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 71,064 | 71,608 | -3,099 | -105,511 | -69,772 |
| Depreciation Amortization | 60,131 | 60,950 | 1,344 | 5,499 | 4,741 |
| Accounts receivable | -5,610 | -6,969 | -2,108 | 6,868 | 9,587 |
| Other Working Capital | -1,832 | 929 | -5,662 | 14,480 | 3,417 |
| Other Operating Activity | -130,867 | -138,341 | 1,303 | 8,999 | -1,388 |
| Operating Cash Flow | $-7,114 | $-11,823 | $-8,222 | $-69,665 | $-53,415 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -277 | -312 | -99 | N/A | N/A |
| Purchase Of Investment | -222,823 | -157,712 | -7,359 | -41,161 | -41,488 |
| Sale Of Investment | 241,000 | 180,500 | 18,000 | 25,000 | 24,798 |
| Other Investing Activity | 0 | 0 | 0 | -6,000 | 0 |
| Investing Cash Flow | $17,900 | $22,476 | $10,542 | $-22,161 | $-16,690 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | N/A | 60,072 | 60,072 |
| Debt Repayment | -372 | -372 | -372 | -43,131 | -43,131 |
| Common Stock Issued | 9,890 | 3,360 | 1,979 | 67,258 | 66,462 |
| Other Financing Activity | 0 | 0 | 0 | -2,091 | -2,091 |
| Financing Cash Flow | $9,518 | $2,988 | $1,607 | $82,108 | $81,312 |
| Exchange Rate Effect | 350 | 286 | -372 | 454 | -217 |
| Beginning Cash Position | 33,785 | 33,785 | 33,785 | 43,049 | 43,049 |
| End Cash Position | 54,439 | 47,712 | 37,340 | 33,785 | 54,039 |
| Net Cash Flow | $20,654 | $13,927 | $3,555 | $-9,264 | $10,990 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,114 | -11,823 | -8,222 | -69,665 | -53,415 |
| Capital Expenditure | -866 | -312 | -99 | N/A | 0 |
| Free Cash Flow | -7,980 | -12,135 | -8,321 | -69,665 | -53,415 |